JE, H., JA, K., A, D., D, S., GHL, R., AE, J., . . . MA, F. (2021). Genome-wide analysis in 756,646 individuals provides first genetic evidence that ACE2 expression influences COVID-19 risk and yields genetic risk scores predictive of severe disease. MedRxiv : the preprint server for health sciences. https://doi.org/10.1101/2020.12.14.20248176
Chicago Style (17th ed.) CitationJE, Horowitz, et al. "Genome-wide Analysis in 756,646 Individuals Provides First Genetic Evidence That ACE2 Expression Influences COVID-19 Risk and Yields Genetic Risk Scores Predictive of Severe Disease." MedRxiv : The Preprint Server for Health Sciences 2021. https://doi.org/10.1101/2020.12.14.20248176.
MLA (9th ed.) CitationJE, Horowitz, et al. "Genome-wide Analysis in 756,646 Individuals Provides First Genetic Evidence That ACE2 Expression Influences COVID-19 Risk and Yields Genetic Risk Scores Predictive of Severe Disease." MedRxiv : The Preprint Server for Health Sciences, 2021, https://doi.org/10.1101/2020.12.14.20248176.